Collecting data to evaluate a mobile app for blood pressure estimation
Data Collection and Evaluation of a Mobile, Machine-learning-based Solution for Blood Pressure Estimation - the OptiBP Study.
This study is testing a new mobile app that uses your smartphone camera to estimate blood pressure and sees how well it works compared to traditional methods.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 500000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Biospectal Industry-sponsored |
| Locations | 1 site (Truckee, California) |
| Trial ID | NCT06017687 on ClinicalTrials.gov |
What this trial studies
This study aims to gather data to assess the effectiveness of a mobile application called OptiBP, which utilizes advanced machine learning techniques to estimate blood pressure. Participants will take blood pressure readings using a traditional cuff-based monitor while simultaneously capturing an optical signal with their smartphone camera. The goal is to evaluate the accuracy and reliability of this innovative approach in estimating blood pressure in a general population setting.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who reside in the United States and have access to both an Android smartphone and a cuff-based blood pressure monitor.
Not a fit: Patients with known skin sensitivities to nickel/chromium or those with hand lesions that prevent proper smartphone camera use may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a convenient and accurate method for individuals to monitor their blood pressure using their smartphones.
How similar studies have performed: While the use of mobile applications for health monitoring is growing, this specific approach utilizing machine learning for blood pressure estimation is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Be at least 18 years old (at least 19 years old in Alabama and Nebraska, at least 21 years old in Puerto Rico); 2. Live in the United States of America 3. Have an Android smartphone 4. Have access to an arm-worn blood pressure monitor (cuff) 5. Have access to the Google Play store to download the OptiBP study app on their phone 6. Be comfortable communicating in written and spoken English 7. Be willing and able to provide informed consent to participate in the study Exclusion Criteria: 1. Known contact dermatitis to nickel/chromium 2. Lesion or deficiency on hand, preventing placing a finger on the smartphone camera 3. Known dysrhythmia like bigeminy, trigeminy, isolated VPB, atrial fibrillation
Where this trial is running
Truckee, California
- Decentralized Trial — Truckee, California, United States (Recruiting)
Study contacts
- Principal investigator: Frederic Frappereau — Biospectal
- Study coordinator: Frederic Frappereau
- Email: study@biospectal.com
- Phone: 650-229-8604
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.